BIOMERIEUX (EPA:BIM) | Finanzwire

Basculer en Français

10800	Companies
233619	Keywords
162289	Articles
124731	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 03/27/2024 at 18:01, 2 years 4 months ago

bioMérieux receives Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
bioMérieux receives 510(k) clearance and CLIA-waiver for BIOFIRE SPOTFIRE R/ST Panel, enhancing diagnostic capabilities for respiratory and sore throat infections globally

BioMérieux 510(k) Clearance BIOFIRE SPOTFIRE R/ST Panel CLIA-waiver Approval Diagnostic Testing
BRIEF

published on 03/25/2024 at 17:35, 2 years 4 months ago

BIOMERIEUX Combined General Meeting Scheduled for May 23, 2024

Shareholders BioMérieux General Assembly Documentation Voting Conditions
REGULATED PRESS RELEASE

published on 03/14/2024 at 07:01, 2 years 4 months ago

bioMérieux – 2023 Financial Results
BRIEF

published on 03/04/2024 at 11:42, 2 years 5 months ago

BioMérieux announces its voting rights figures for February 2024

Share Capital Voting Rights BioMérieux Regulation February 2024
REGULATED PRESS RELEASE

published on 01/16/2024 at 07:01, 2 years 6 months ago

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D
bioMérieux, a world leader in in vitro diagnostics, announces the appointment of two new Executive Committee members, Dr. Charles K. Cooper and Céline Roger-Dalbert, to lead Medical Affairs and Research & Development, respectively. Dr. Cooper brings extensive medical and leadership background from Siemens Healthcare Diagnostics and U.S. Food & Drug Administration, while Céline Roger-Dalbert boasts over 25 years of in vitro diagnostic experience, with significant contributions to new product launches and over 20 patent applications. Their nominations signify bioMérieux's commitment to addressing global patients' needs and driving innovation, aligning with the company's strategy. For more information, visit www.biomerieux.com.

BioMérieux Medical Affairs Research And Development In Vitro Diagnostics Executive Committee Members
REGULATED PRESS RELEASE

published on 01/08/2024 at 08:22, 2 years 6 months ago

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
bioMérieux has acquired LUMED, a software company specializing in clinical decision support systems to optimize antimicrobial prescriptions and monitor healthcare-associated infections. This acquisition reinforces bioMérieux's commitment to combat antimicrobial resistance and improve infection prevention and control through advanced software solutions.

BioMérieux LUMED Antimicrobial Resistance Clinical Decision Support System Infection Prevention And Control
REGULATED PRESS RELEASE

published on 10/26/2023 at 07:01, 2 years 9 months ago

bioMérieux – Third-Quarter 2023 Business Review
REGULATED PRESS RELEASE

published on 10/19/2023 at 08:00, 2 years 9 months ago

bioMérieux makes strategic investment in Oxford Nanopore
REGULATED PRESS RELEASE

published on 10/13/2023 at 07:02, 2 years 9 months ago

bioMérieux announces CE-marking of VIDAS® TBI (GFAP, UCH-L1), a test for improved assessment of patients with mild traumatic brain injury, including concussion

Accesswire

Published on 08/05/2026 at 02:10, 2 hours 47 minutes ago

Kleen Hy-Dro-Gen Inc. Is Pleased to Announce Dual ISO 9001:2015 and TSSA Certifications, Bolstering Operational Quality and Technical Safety Governance
Published on 08/04/2026 at 22:30, 6 hours 27 minutes ago

Nextech3D.ai Provides Update on Acquisition of Remaining ARway Shares
Published on 08/04/2026 at 22:00, 6 hours 57 minutes ago

Lockheed Martin and NioCorp Sign MOU
Published on 08/04/2026 at 16:25, 12 hours 32 minutes ago

ACCESS Newswire to Host Second Quarter Earnings Conference Call on August 11, 2026
Published on 08/04/2026 at 15:00, 13 hours 57 minutes ago

Infield Minerals Expands Land Position at the Kings Canyon Gold Project in Utah

View all ACCESSWIRE

EQS Group

Published on 08/04/2026 at 22:03, 6 hours 54 minutes ago

#FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
Published on 08/04/2026 at 22:01, 6 hours 56 minutes ago

EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Published on 08/04/2026 at 20:05, 8 hours 52 minutes ago

Hard Rock Cafe and Coca-Cola® Launch Hard Rock Rising Music Competition for Emerging Artists
Published on 08/04/2026 at 19:40, 9 hours 17 minutes ago

NNS acquires shares in OCI
Published on 08/04/2026 at 19:39, 9 hours 18 minutes ago

EQS-Adhoc: Basler AG financial results for the first 6 months of 2026: Strong business performance in the first half of the year; company raises its 2026 forecast once again

Les Echos

Published on 08/04/2026 at 19:16, 9 hours 41 minutes ago

Covivio - 2026 Half-year financial report
Published on 08/04/2026 at 18:32, 10 hours 25 minutes ago

Total number of voting rights and shares making up the share capital at July 31, 2026
Published on 08/04/2026 at 17:45, 11 hours 12 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 08/04/2026 at 16:00, 12 hours 57 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 08/04/2026 at 08:15, 20 hours 42 minutes ago

Covivio - Conditions of availability of the 2026 Half-year report

View all LES ECHOS COMFI WIRE